3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
19
Myelodysplastic Syndromes
7
Leukemia, Hairy Cell
4
Leukemia, Biphenotypic, Acute
4
Recurrence
3
Leukemia
3
Sarcoma, Myeloid
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Blast Crisis
2
Targeted Therapy
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myasthenia Gravis
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cyclophosphamide
9
Rituximab
5
glofitamab
4
Whole-Body Irradiation
4
fludarabine phosphate
3
fludarabine
3
Mycophenolic Acid
3
Melphalan
3
Doxorubicin
3
polatuzumab vedotin
2
pirtobrutinib
2
pembrolizumab
2
obinutuzumab
2
Tacrolimus
2
Sirolimus
2
Prednisone
2
Lenalidomide
2
Busulfan
2
zanubrutinib
1
venetoclax
1
relmacabtagene autoleucel
1
pegfilgrastim
1
axicabtagene ciloleucel
1
Weights and Measures
1
Vincristine
1
Triamcinolone
1
Specimen Handling
1
Receptors, Chimeric Antigen
1
Prednisolone
1
Peripheral Blood Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Cladribine
×
1 year
×
Clear all
No trials found.